Publishing of Canatu's Half-Year Report and Webcast Presentation on 25 August 2026
Canatu Plc Press Release 17 August 2026 at 9:00 a.m. EEST
Publishing of Canatu’s Half-Year Report and Webcast Presentation on 25 August 2026
Canatu Plc (CANATU, Nasdaq First North, Finland) will publish its Half-Year Report for 1 January – 30 June 2026 on Tuesday, 25 August 2026, at approximately 9:00 a.m. EEST.
Canatu’s CEO Dr. Maximilian Slawinski and CFO Mikko Vesterinen will present the results and Canatu’s business and outlook in a webcast on 25 August 2026 from 12:00 p.m. to 1:00 p.m. EEST. The webcast will mark Slawinski’s first investor presentation as CEO of Canatu.
Registration and access to the webcast are available via the following link: https://canatu.events.inderes.com/q2-2026.
The presentation material and a recording of the event will be available shortly afterwards on Canatu’s Reports and Presentations webpage: https://canatu.com/investors/reports-and-presentations/.
The event will be hosted from Sanomatalo (Studio Eero, Töölölahdenkatu 2, Helsinki). Due to limited seating capacity, attendance is possible only via webcast.
Additional information
Mikko Vesterinen, CFO, mikko.vesterinen@canatu.com
Maximilian Slawinski, CEO, maximilian.slawinski@canatu.com
Certified adviser
DNB Carnegie Investment Bank AB (publ), tel. +46 (0) 8 588 685 70
About Canatu
Canatu (CANATU, Nasdaq First North, Finland) is a deep technology scaleup company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, robotics, mobility and defense, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.
Canatu’s versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling more effective manufacturing of the most advanced chips. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and dry deposition method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.
Headquartered in Finland, Canatu also operates in the US, Japan and Taiwan. Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu currently has 185 full-time equivalent employees representing over 35 nationalities, with nearly 20% holding or pursuing doctorates. Discover more at www.canatu.com and follow us on LinkedIn.